ErbB2 expression through heterodimerization with erbB1 is necessary for ionizing radiation- but not EGF-induced activation of Akt survival pathway

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 338-345

  Toulany, Mahmoud ^a   Minjgee, Minjmaa ^a   Kehlbach, Rainer ^a   Chen, Jianyong ^b   Baumann, Michael ^c   Rodemann, H Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Akt phosphorylation; ErbB1 erbB2 signaling; Ionizing radiation

Indexed keywords

5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; DOUBLE STRANDED DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; HISTONE H2AX; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRASTUZUMAB;

ARTICLE; CANCER CELL; CELL SURVIVAL; DIMERIZATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIZATION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-1; HUMANS; INFRARED RAYS; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 78149358861     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.03.008     Document Type: Article

References (62)

1. K. Dittmann, C. Mayer, and R. Kehlbach Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport Radiother Oncol 92 2009 379 382
2. P.M. Harari Epidermal growth factor receptor inhibition strategies in oncology Endocr Relat Cancer 11 2004 689 708
3. P.M. Harari, and S. Huang Radiation combined with EGFR signal inhibitors: head and neck cancer focus Semin Radiat Oncol 16 2006 38 44
4. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
5. M.K. Nyati, M.A. Morgan, and F.Y. Feng Integration of EGFR inhibitors with radiochemotherapy Nat Rev Cancer 6 2006 876 885
6. N. Zhang, K. Erjala, and J. Kulmala Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro Radiother Oncol 92 2009 388 392
7. M. Baumann, M. Krause, and E. Dikomey EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms Radiother Oncol 83 2007 238 248
8. J.G. Eriksen, and M. Overgaard Late onset of skin toxicity induced by EGFr-inhibitors Radiother Oncol 90 2009 280 281
9. M.C. Merlano, and E.G. Russi Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: "Koebner- Phenomenon" or radio-dermatitis? Radiother Oncol 92 2009 142 143
10. H.M. Shepard, C.M. Brdlik, and H. Schreiber Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family J Clin Invest 118 2008 3574 3581
11. H.C. Lee, S. An, and H. Lee Activation of epidermal growth factor receptor and its downstream signaling pathway by nitric oxide in response to ionizing radiation Mol Cancer Res 6 2008 996 1002
12. Z. Jing, L. Gong, and C.Y. Xie Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab Radiother Oncol 93 2009 468 473
13. M.J. Sambade, J.T. Camp, and R.J. Kimple Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf > MEK > ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK Radiother Oncol 93 2009 639 644
14. G. Wanner, C. Mayer, and R. Kehlbach Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation Radiother Oncol 86 2008 383 390
15. J.A. Bonner, H.Q. Trummell, and C.D. Willey Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma Radiother Oncol 92 2009 339 344
16. N.E. Hynes, and G. Macdonald ErbB receptors and signaling pathways in cancer Curr Opin Cell Biol 21 2009 177 184
17. I.A. Kim, M. No, and J.M. Lee Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6 Radiother Oncol 92 2009 125 132
18. D. Hambardzumyan, O.J. Becher, and M.K. Rosenblum PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo Genes Dev 22 2008 436 448
19. K.M. Nicholson, and N.G. Anderson The protein kinase B/Akt signalling pathway in human malignancy Cell Signal 14 2002 381 395
20. E. Fayard, L.A. Tintignac, and A. Baudry Protein kinase B/Akt at a glance J Cell Sci 118 2005 5675 5678
21. F. Cappuzzo, E. Magrini, and G.L. Ceresoli Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer J Natl Cancer Inst 96 2004 1133 1141 (Pubitemid 39207049)
22. M. Toulany, K. Dittmann, and M. Baumann Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS Radiother Oncol 74 2005 117 129
23. M. Toulany, U. Kasten-Pisula, and I. Brammer Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair Clin Cancer Res 12 2006 4119 4126
24. K. Dittmann, C. Mayer, and B. Fehrenbacher Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase J Biol Chem 280 2005 31182 31189
25. M. Toulany, K. Dittmann, and M. Kruger Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway Radiother Oncol 76 2005 143 150
26. M. Toulany, M. Baumann, and H.P. Rodemann Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity Mol Cancer Res 5 2007 863 872
27. T.J. Kim, J.W. Lee, and S.Y. Song Increased expression of pAKT is associated with radiation resistance in cervical cancer Br J Cancer 94 2006 1678 1682
28. E. Tokunaga, A. Kataoka, and Y. Kimura The association between Akt activation and resistance to hormone therapy in metastatic breast cancer Eur J Cancer 42 2006 629 635
29. J. Brognard, A.S. Clark, and Y. Ni Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Res 61 2001 3986 3997
30. J. Qian, Y. Zou, and J.S. Rahman Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung Mol Cancer Ther 8 2009 101 109
31. M. Toulany, R. Kehlbach, and U. Florczak Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair Mol Cancer Ther 7 2008 1772 1781
32. G.D. Kao, Z. Jiang, and A.M. Fernandes Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation J Biol Chem 282 2007 21206 21212
33. J.P. Plastaras, J.F. Dorsey, and K. Carroll Role of PI3K/Akt signaling in TRAIL- and radiation-induced gastrointestinal apoptosis Cancer Biol Ther 7 2008 2047 2053
34. G. Hudelist, C.F. Singer, and M. Manavi Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors Breast Cancer Res Treat 80 2003 353 361
35. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127 137
36. D.J. Slamon, W. Godolphin, and L.A. Jones Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
37. R.F. Lodato, H.C. Maguire Jr., and M.I. Greene Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast Mod Pathol 3 1990 449 454
38. J.A. Kern, D.A. Schwartz, and J.E. Nordberg P185neu expression in human lung adenocarcinomas predicts shortened survival Cancer Res 50 1990 5184 5187
39. D.B. Weiner, J. Nordberg, and R. Robinson Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung Cancer Res 50 1990 421 425
40. S. Kuyama, K. Hotta, and M. Tabata Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer J Thorac Oncol 3 2008 477 482
41. M. Lerdrup, S. Bruun, and M.V. Grandal Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus Mol Biol Cell 18 2007 3656 3666
42. M.A. Molina, J. Codony-Servat, and J. Albanell Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells Cancer Res 61 2001 4744 4749
43. M. Toulany, K. Dittmann, and B. Fehrenbacher PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro DNA Repair (Amst) 7 2008 1746 1756
44. M. Egeblad, O.H. Mortensen, and L.C. van Kempen BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells Biochem Biophys Res Commun 281 2001 25 31
45. H.P. Rodemann, K. Dittmann, and M. Toulany Radiation-induced EGFR-signaling and control of DNA-damage repair Int J Radiat Biol 83 2007 781 791
46. L. Bozulic, B. Surucu, and D. Hynx PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival Mol Cell 30 2008 203 213
47. B. Mukherjee, B. McEllin, and C.V. Camacho EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma Cancer Res 69 2009 4252 4259
48. C.A. Hudis Trastuzumab - mechanism of action and use in clinical practice N Engl J Med 357 2007 39 51
49. I.A. Kim, S.S. Bae, and A. Fernandes Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines Cancer Res 65 2005 7902 7910
50. J.M. Tang, Q.Y. He, and R.X. Guo Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis Lung Cancer 51 2006 181 191
51. H. Nakamura, N. Kawasaki, and M. Taguchi Association of HER-2 overexpression with prognosis in nonsmall cell lung carcinoma: a metaanalysis Cancer 103 2005 1865 1873
52. B. Li, C.M. Chang, and M. Yuan Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas Cancer Res 63 2003 7443 7450
53. G. Lammering, K. Valerie, and P.S. Lin Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor Clin Cancer Res 7 2001 682 690
54. R.E. Meyn, A. Munshi, and J.V. Haymach Receptor signaling as a regulatory mechanism of DNA repair Radiother Oncol 92 2009 316 322
55. B.P. Chen, N. Uematsu, and J. Kobayashi Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break J Biol Chem 282 2007 6582 6587
56. T.A. Christianson, J.K. Doherty, and Y.J. Lin NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer Cancer Res 58 1998 5123 5129
57. M.Z. Gilcrease, W.A. Woodward, and M.M. Nicolas Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer Am J Surg Pathol 33 2009 759 767
58. T. Nishioka, C.M. West, and N. Gupta Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy J Cancer Res Clin Oncol 125 1999 96 100
59. E.M. Bublil, and Y. Yarden The EGF receptor family: spearheading a merger of signaling and therapeutics Curr Opin Cell Biol 19 2007 124 134
60. R.H. Tao, and I.N. Maruyama All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells J Cell Sci 121 2008 3207 3217
61. C. Bianco, G. Tortora, and R. Bianco Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa) Clin Cancer Res 8 2002 3250 3258
62. K. Liang, Y. Lu, and W. Jin Sensitization of breast cancer cells to radiation by trastuzumab Mol Cancer Ther 2 2003 1113 1120